Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+43.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+43.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202588.30%
2024-494.89%
2023-56.44%
202230.12%
2021-1.26%
2020-33.61%
2019-260.61%
20180.00%